Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioLife Solutions' CFO Sells 30,000 Shares


This bioproduction tools provider for cell and gene therapy reported a notable insider sale amid a modestly downtrending share price.

Troy Wichterman, Chief Financial Officer of BioLife Solutions (NASDAQ:BLFS), directly sold 30,000 shares on Dec. 4, for a transaction value of approximately $771,600, according to the SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average sale price ($25.72); post-Transaction value based on Dec. 4 market close of $25.83 (price not specified in filing).

Continue reading


Source Fool.com

Biolife Solutions Inc Stock

€21.00
0.960%
The Biolife Solutions Inc stock is trending slightly upwards today, with an increase of €0.20 (0.960%) compared to yesterday's price.

Like: 0
Share

Comments